Evolutionary Genomics, Inc. (FNAM) financial statements (2021 and earlier)

Company profile

Business Address 1026 ANACONDA DRIVE
CASTLE ROCK, CO 80108
State of Incorp. NV
Fiscal Year End December 31
SIC 8731 - Commercial Physical and Biological Research (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments216871601,1712,122262 
Cash and cash equivalents216451318802,0584 
Short-term investments 422829164258 
Receivables 740 916 
Prepaid expense622423222222 
Total current assets:2781182231,1932,154300 
Noncurrent Assets
Property, plant and equipment5189127165206139 
Long-term investments and receivables     172 
Long-term investments     172 
Intangible assets, net (including goodwill)3,6644,0364,0384,0414,0432,560 
Intangible assets, net (excluding goodwill)3,6644,0364,0384,0414,0432,560 
Total noncurrent assets:3,7154,1244,1654,2064,2492,871 
TOTAL ASSETS:3,9934,2434,3895,3996,4033,171 
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:319 1146140 
Interest and dividends payable1,236      
Other undisclosed accounts payable and accrued liabilities(1,233)19 1146140 
Due to related parties      14
Billings in excess of cost  114 
Total current liabilities:319 114625414
Noncurrent Liabilities
Long-term debt and lease obligation2,246      
Long-term debt, excluding current maturities2,246      
Liabilities, other than long-term debt 9879559551,486  
Deferred tax liabilities, net9559551,486  
Deferred income tax liabilities 987
Total noncurrent liabilities:2,2469879559551,486  
Total liabilities:2,2491,0079559661,53225414
Temporary equity, carrying amount3,5703,5703,0303,0303,030  
Stockholders' equity
Stockholders' equity attributable to parent, including:(1,826)(334)4041,4041,8412,917(14)
Preferred stock1,236951  197  
Common stock6666668
Additional paid in capital12,01612,08112,29512,43912,57912,6991,312
Accumulated deficit(15,084)(13,372)(12,579)(11,480)(10,940)(9,788)(1,334)
Other undisclosed stockholders' equity attributable to parent  681439   
Total stockholders' equity:(1,826)(334)4041,4041,8412,917(14)
TOTAL LIABILITIES AND EQUITY:3,9934,2434,3895,3996,4033,171 

Income statement (P&L) ($ in thousands)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues1312311533222263 
Cost of revenue
(Cost of Goods and Services Sold)
     (147) 
Gross profit:1312311533222116 
Operating expenses(2,892)(898)(952)(1,335)(1,275)(839)(25)
Other operating expense, net
(Other Expenses)
      (0)
Other undisclosed operating income      0
Operating loss:(2,880)(775)(837)(1,303)(1,053)(723)(25)
Nonoperating income (expense)18114(262)233(99)437(3)
Investment income, nonoperating001233(99)25 
Other nonoperating expense      (3)
Interest and debt expense74     (3)
Loss from continuing operations before equity method investments, income taxes:(2,625)(761)(1,099)(1,070)(1,152)(286)(30)
Other undisclosed loss from continuing operations before income taxes(74)      
Loss from continuing operations before income taxes:(2,699)(761)(1,099)(1,070)(1,152)(286)(30)
Income tax expense (benefit)987(32) 530   
Net loss:(1,712)(793)(1,099)(540)(1,152)(286)(30)
Other undisclosed net income attributable to parent      3
Net loss attributable to parent:(1,712)(793)(1,099)(540)(1,152)(286)(27)
Preferred stock dividends and other adjustments(286)(269)(242)(242)(197)  
Net loss available to common stockholders, diluted:(1,997)(1,063)(1,341)(782)(1,349)(286)(27)

Comprehensive Income ($ in thousands)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(1,712)(793)(1,099)(540)(1,152)(286)(30)
Comprehensive loss, net of tax, attributable to parent:(1,712)(793)(1,099)(540)(1,152)(286)(30)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: